Chimeric Antigen Receptor Cell Therapy Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Acute Leukemia
1.3.3 Non-hodgkin's Lymphoma
1.3.4 Multiple Myeloma
1.3.5 Transplant Rejection
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chimeric Antigen Receptor Cell Therapy Market Perspective (2017-2028)
2.2 Chimeric Antigen Receptor Cell Therapy Growth Trends by Region
2.2.1 Chimeric Antigen Receptor Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Chimeric Antigen Receptor Cell Therapy Historic Market Size by Region (2017-2022)
2.2.3 Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Region (2023-2028)
2.3 Chimeric Antigen Receptor Cell Therapy Market Dynamics
2.3.1 Chimeric Antigen Receptor Cell Therapy Industry Trends
2.3.2 Chimeric Antigen Receptor Cell Therapy Market Drivers
2.3.3 Chimeric Antigen Receptor Cell Therapy Market Challenges
2.3.4 Chimeric Antigen Receptor Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chimeric Antigen Receptor Cell Therapy Players by Revenue
3.1.1 Global Top Chimeric Antigen Receptor Cell Therapy Players by Revenue (2017-2022)
3.1.2 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Chimeric Antigen Receptor Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chimeric Antigen Receptor Cell Therapy Revenue
3.4 Global Chimeric Antigen Receptor Cell Therapy Market Concentration Ratio
3.4.1 Global Chimeric Antigen Receptor Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chimeric Antigen Receptor Cell Therapy Revenue in 2021
3.5 Chimeric Antigen Receptor Cell Therapy Key Players Head office and Area Served
3.6 Key Players Chimeric Antigen Receptor Cell Therapy Product Solution and Service
3.7 Date of Enter into Chimeric Antigen Receptor Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chimeric Antigen Receptor Cell Therapy Breakdown Data by Type
4.1 Global Chimeric Antigen Receptor Cell Therapy Historic Market Size by Type (2017-2022)
4.2 Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Type (2023-2028)
5 Chimeric Antigen Receptor Cell Therapy Breakdown Data by Application
5.1 Global Chimeric Antigen Receptor Cell Therapy Historic Market Size by Application (2017-2022)
5.2 Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Chimeric Antigen Receptor Cell Therapy Market Size (2017-2028)
6.2 North America Chimeric Antigen Receptor Cell Therapy Market Size by Type
6.2.1 North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022)
6.2.2 North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028)
6.2.3 North America Chimeric Antigen Receptor Cell Therapy Market Share by Type (2017-2028)
6.3 North America Chimeric Antigen Receptor Cell Therapy Market Size by Application
6.3.1 North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022)
6.3.2 North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028)
6.3.3 North America Chimeric Antigen Receptor Cell Therapy Market Share by Application (2017-2028)
6.4 North America Chimeric Antigen Receptor Cell Therapy Market Size by Country
6.4.1 North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022)
6.4.2 North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size (2017-2028)
7.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type
7.2.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022)
7.2.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028)
7.2.3 Europe Chimeric Antigen Receptor Cell Therapy Market Share by Type (2017-2028)
7.3 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application
7.3.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022)
7.3.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028)
7.3.3 Europe Chimeric Antigen Receptor Cell Therapy Market Share by Application (2017-2028)
7.4 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country
7.4.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022)
7.4.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size (2017-2028)
8.2 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Type
8.2.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Application
8.3.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region
8.4.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chimeric Antigen Receptor Cell Therapy Market Size (2017-2028)
9.2 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Type
9.2.1 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Chimeric Antigen Receptor Cell Therapy Market Share by Type (2017-2028)
9.3 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Application
9.3.1 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Chimeric Antigen Receptor Cell Therapy Market Share by Application (2017-2028)
9.4 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country
9.4.1 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size (2017-2028)
10.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type
10.2.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application
10.3.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country
10.4.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Company Details
11.1.2 Amgen Inc Business Overview
11.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.1.4 Amgen Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.1.5 Amgen Inc Recent Developments
11.2 Autolus Therapeutics Plc
11.2.1 Autolus Therapeutics Plc Company Details
11.2.2 Autolus Therapeutics Plc Business Overview
11.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Introduction
11.2.4 Autolus Therapeutics Plc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.2.5 Autolus Therapeutics Plc Recent Developments
11.3 Beijing Immunochina Medical Science & Technology Co Ltd
11.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details
11.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Developments
11.4 Bellicum Pharmaceuticals Inc
11.4.1 Bellicum Pharmaceuticals Inc Company Details
11.4.2 Bellicum Pharmaceuticals Inc Business Overview
11.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.4.4 Bellicum Pharmaceuticals Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.4.5 Bellicum Pharmaceuticals Inc Recent Developments
11.5 Bristol-Myers Squibb Co
11.5.1 Bristol-Myers Squibb Co Company Details
11.5.2 Bristol-Myers Squibb Co Business Overview
11.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Introduction
11.5.4 Bristol-Myers Squibb Co Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.5.5 Bristol-Myers Squibb Co Recent Developments
11.6 bluebird bio Inc
11.6.1 bluebird bio Inc Company Details
11.6.2 bluebird bio Inc Business Overview
11.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.6.4 bluebird bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.6.5 bluebird bio Inc Recent Developments
11.7 CARsgen Therapeutics Ltd
11.7.1 CARsgen Therapeutics Ltd Company Details
11.7.2 CARsgen Therapeutics Ltd Business Overview
11.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.7.4 CARsgen Therapeutics Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.7.5 CARsgen Therapeutics Ltd Recent Developments
11.8 Celgene Corp
11.8.1 Celgene Corp Company Details
11.8.2 Celgene Corp Business Overview
11.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Introduction
11.8.4 Celgene Corp Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.8.5 Celgene Corp Recent Developments
11.9 Cell Medica Ltd
11.9.1 Cell Medica Ltd Company Details
11.9.2 Cell Medica Ltd Business Overview
11.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.9.4 Cell Medica Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.9.5 Cell Medica Ltd Recent Developments
11.10 Cellular Biomedicine Group Inc
11.10.1 Cellular Biomedicine Group Inc Company Details
11.10.2 Cellular Biomedicine Group Inc Business Overview
11.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.10.4 Cellular Biomedicine Group Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.10.5 Cellular Biomedicine Group Inc Recent Developments
11.11 Celularity Inc
11.11.1 Celularity Inc Company Details
11.11.2 Celularity Inc Business Overview
11.11.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.11.4 Celularity Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.11.5 Celularity Inc Recent Developments
11.12 Celyad SA
11.12.1 Celyad SA Company Details
11.12.2 Celyad SA Business Overview
11.12.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Introduction
11.12.4 Celyad SA Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.12.5 Celyad SA Recent Developments
11.13 Daiichi Sankyo Co Ltd
11.13.1 Daiichi Sankyo Co Ltd Company Details
11.13.2 Daiichi Sankyo Co Ltd Business Overview
11.13.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.13.4 Daiichi Sankyo Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.13.5 Daiichi Sankyo Co Ltd Recent Developments
11.14 Fosun Pharmaceutical AG
11.14.1 Fosun Pharmaceutical AG Company Details
11.14.2 Fosun Pharmaceutical AG Business Overview
11.14.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Introduction
11.14.4 Fosun Pharmaceutical AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.14.5 Fosun Pharmaceutical AG Recent Developments
11.15 Gilead Sciences Inc
11.15.1 Gilead Sciences Inc Company Details
11.15.2 Gilead Sciences Inc Business Overview
11.15.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.15.4 Gilead Sciences Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.15.5 Gilead Sciences Inc Recent Developments
11.16 Guangzhou Anjie Biomedical Technology Co Ltd
11.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Details
11.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
11.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Developments
11.17 Hangzhou Converd Co Ltd
11.17.1 Hangzhou Converd Co Ltd Company Details
11.17.2 Hangzhou Converd Co Ltd Business Overview
11.17.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.17.4 Hangzhou Converd Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.17.5 Hangzhou Converd Co Ltd Recent Developments
11.18 Hebei Senlang Biotechnology Inc Ltd
11.18.1 Hebei Senlang Biotechnology Inc Ltd Company Details
11.18.2 Hebei Senlang Biotechnology Inc Ltd Business Overview
11.18.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.18.4 Hebei Senlang Biotechnology Inc Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Developments
11.19 HRAIN Biotechnology Co Ltd
11.19.1 HRAIN Biotechnology Co Ltd Company Details
11.19.2 HRAIN Biotechnology Co Ltd Business Overview
11.19.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.19.4 HRAIN Biotechnology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.19.5 HRAIN Biotechnology Co Ltd Recent Developments
11.20 Juno Therapeutics Inc
11.20.1 Juno Therapeutics Inc Company Details
11.20.2 Juno Therapeutics Inc Business Overview
11.20.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.20.4 Juno Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.20.5 Juno Therapeutics Inc Recent Developments
11.21 Kite Pharma Inc
11.21.1 Kite Pharma Inc Company Details
11.21.2 Kite Pharma Inc Business Overview
11.21.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.21.4 Kite Pharma Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.21.5 Kite Pharma Inc Recent Developments
11.22 Nanjing Legend Biotech Co Ltd
11.22.1 Nanjing Legend Biotech Co Ltd Company Details
11.22.2 Nanjing Legend Biotech Co Ltd Business Overview
11.22.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.22.4 Nanjing Legend Biotech Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.22.5 Nanjing Legend Biotech Co Ltd Recent Developments
11.23 NantKwest Inc
11.23.1 NantKwest Inc Company Details
11.23.2 NantKwest Inc Business Overview
11.23.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.23.4 NantKwest Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.23.5 NantKwest Inc Recent Developments
11.24 Nkarta Inc
11.24.1 Nkarta Inc Company Details
11.24.2 Nkarta Inc Business Overview
11.24.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.24.4 Nkarta Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.24.5 Nkarta Inc Recent Developments
11.25 Novartis AG
11.25.1 Novartis AG Company Details
11.25.2 Novartis AG Business Overview
11.25.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Introduction
11.25.4 Novartis AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.25.5 Novartis AG Recent Developments
11.26 Ono Pharmaceutical Co Ltd
11.26.1 Ono Pharmaceutical Co Ltd Company Details
11.26.2 Ono Pharmaceutical Co Ltd Business Overview
11.26.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.26.4 Ono Pharmaceutical Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.26.5 Ono Pharmaceutical Co Ltd Recent Developments
11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
11.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
11.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
11.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Developments
11.28 Sorrento Therapeutics Inc
11.28.1 Sorrento Therapeutics Inc Company Details
11.28.2 Sorrento Therapeutics Inc Business Overview
11.28.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.28.4 Sorrento Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.28.5 Sorrento Therapeutics Inc Recent Developments
11.29 Takara Bio Inc
11.29.1 Takara Bio Inc Company Details
11.29.2 Takara Bio Inc Business Overview
11.29.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.29.4 Takara Bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.29.5 Takara Bio Inc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Chimeric Antigen Receptor Cell Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Chimeric Antigen Receptor Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Chimeric Antigen Receptor Cell Therapy Market Share by Region (2017-2022)
Table 8. Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Chimeric Antigen Receptor Cell Therapy Market Share by Region (2023-2028)
Table 10. Chimeric Antigen Receptor Cell Therapy Market Trends
Table 11. Chimeric Antigen Receptor Cell Therapy Market Drivers
Table 12. Chimeric Antigen Receptor Cell Therapy Market Challenges
Table 13. Chimeric Antigen Receptor Cell Therapy Market Restraints
Table 14. Global Chimeric Antigen Receptor Cell Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Players (2017-2022)
Table 16. Global Top Chimeric Antigen Receptor Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor Cell Therapy as of 2021)
Table 17. Ranking of Global Top Chimeric Antigen Receptor Cell Therapy Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Chimeric Antigen Receptor Cell Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Chimeric Antigen Receptor Cell Therapy Product Solution and Service
Table 21. Date of Enter into Chimeric Antigen Receptor Cell Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Type (2017-2022)
Table 25. Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Type (2023-2028)
Table 27. Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Application (2017-2022)
Table 29. Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Application (2023-2028)
Table 31. North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 61. Amgen Inc Company Details
Table 62. Amgen Inc Business Overview
Table 63. Amgen Inc Chimeric Antigen Receptor Cell Therapy Product
Table 64. Amgen Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 65. Amgen Inc Recent Developments
Table 66. Autolus Therapeutics Plc Company Details
Table 67. Autolus Therapeutics Plc Business Overview
Table 68. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product
Table 69. Autolus Therapeutics Plc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 70. Autolus Therapeutics Plc Recent Developments
Table 71. Beijing Immunochina Medical Science & Technology Co Ltd Company Details
Table 72. Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
Table 73. Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product
Table 74. Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 75. Beijing Immunochina Medical Science & Technology Co Ltd Recent Developments
Table 76. Bellicum Pharmaceuticals Inc Company Details
Table 77. Bellicum Pharmaceuticals Inc Business Overview
Table 78. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product
Table 79. Bellicum Pharmaceuticals Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 80. Bellicum Pharmaceuticals Inc Recent Developments
Table 81. Bristol-Myers Squibb Co Company Details
Table 82. Bristol-Myers Squibb Co Business Overview
Table 83. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product
Table 84. Bristol-Myers Squibb Co Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 85. Bristol-Myers Squibb Co Recent Developments
Table 86. bluebird bio Inc Company Details
Table 87. bluebird bio Inc Business Overview
Table 88. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product
Table 89. bluebird bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 90. bluebird bio Inc Recent Developments
Table 91. CARsgen Therapeutics Ltd Company Details
Table 92. CARsgen Therapeutics Ltd Business Overview
Table 93. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product
Table 94. CARsgen Therapeutics Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 95. CARsgen Therapeutics Ltd Recent Developments
Table 96. Celgene Corp Company Details
Table 97. Celgene Corp Business Overview
Table 98. Celgene Corp Chimeric Antigen Receptor Cell Therapy Product
Table 99. Celgene Corp Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 100. Celgene Corp Recent Developments
Table 101. Cell Medica Ltd Company Details
Table 102. Cell Medica Ltd Business Overview
Table 103. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product
Table 104. Cell Medica Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 105. Cell Medica Ltd Recent Developments
Table 106. Cellular Biomedicine Group Inc Company Details
Table 107. Cellular Biomedicine Group Inc Business Overview
Table 108. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product
Table 109. Cellular Biomedicine Group Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 110. Cellular Biomedicine Group Inc Recent Developments
Table 111. Celularity Inc Company Details
Table 112. Celularity Inc Business Overview
Table 113. Celularity Inc Chimeric Antigen Receptor Cell Therapy Product
Table 114. Celularity Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 115. Celularity Inc Recent Developments
Table 116. Celyad SA Company Details
Table 117. Celyad SA Business Overview
Table 118. Celyad SA Chimeric Antigen Receptor Cell Therapy Product
Table 119. Celyad SA Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 120. Celyad SA Recent Developments
Table 121. Daiichi Sankyo Co Ltd Company Details
Table 122. Daiichi Sankyo Co Ltd Business Overview
Table 123. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product
Table 124. Daiichi Sankyo Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 125. Daiichi Sankyo Co Ltd Recent Developments
Table 126. Fosun Pharmaceutical AG Company Details
Table 127. Fosun Pharmaceutical AG Business Overview
Table 128. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product
Table 129. Fosun Pharmaceutical AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 130. Fosun Pharmaceutical AG Recent Developments
Table 131. Gilead Sciences Inc Company Details
Table 132. Gilead Sciences Inc Business Overview
Table 133. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product
Table 134. Gilead Sciences Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 135. Gilead Sciences Inc Recent Developments
Table 136. Guangzhou Anjie Biomedical Technology Co Ltd Company Details
Table 137. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
Table 138. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product
Table 139. Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 140. Guangzhou Anjie Biomedical Technology Co Ltd Recent Developments
Table 141. Hangzhou Converd Co Ltd Company Details
Table 142. Hangzhou Converd Co Ltd Business Overview
Table 143. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product
Table 144. Hangzhou Converd Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 145. Hangzhou Converd Co Ltd Recent Developments
Table 146. Hebei Senlang Biotechnology Inc Ltd Company Details
Table 147. Hebei Senlang Biotechnology Inc Ltd Business Overview
Table 148. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product
Table 149. Hebei Senlang Biotechnology Inc Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 150. Hebei Senlang Biotechnology Inc Ltd Recent Developments
Table 151. HRAIN Biotechnology Co Ltd Company Details
Table 152. HRAIN Biotechnology Co Ltd Business Overview
Table 153. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product
Table 154. HRAIN Biotechnology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 155. HRAIN Biotechnology Co Ltd Recent Developments
Table 156. Juno Therapeutics Inc Company Details
Table 157. Juno Therapeutics Inc Business Overview
Table 158. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product
Table 159. Juno Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 160. Juno Therapeutics Inc Recent Developments
Table 161. Kite Pharma Inc Company Details
Table 162. Kite Pharma Inc Business Overview
Table 163. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product
Table 164. Kite Pharma Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 165. Kite Pharma Inc Recent Developments
Table 166. Nanjing Legend Biotech Co Ltd Company Details
Table 167. Nanjing Legend Biotech Co Ltd Business Overview
Table 168. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product
Table 169. Nanjing Legend Biotech Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 170. Nanjing Legend Biotech Co Ltd Recent Developments
Table 171. NantKwest Inc Company Details
Table 172. NantKwest Inc Business Overview
Table 173. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product
Table 174. NantKwest Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 175. NantKwest Inc Recent Developments
Table 176. Nkarta Inc Company Details
Table 177. Nkarta Inc Business Overview
Table 178. Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product
Table 179. Nkarta Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 180. Nkarta Inc Recent Developments
Table 181. Novartis AG Company Details
Table 182. Novartis AG Business Overview
Table 183. Novartis AG Chimeric Antigen Receptor Cell Therapy Product
Table 184. Novartis AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 185. Novartis AG Recent Developments
Table 186. Ono Pharmaceutical Co Ltd Company Details
Table 187. Ono Pharmaceutical Co Ltd Business Overview
Table 188. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product
Table 189. Ono Pharmaceutical Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 190. Ono Pharmaceutical Co Ltd Recent Developments
Table 191. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
Table 192. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
Table 193. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product
Table 194. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 195. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Developments
Table 196. Sorrento Therapeutics Inc Company Details
Table 197. Sorrento Therapeutics Inc Business Overview
Table 198. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product
Table 199. Sorrento Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 200. Sorrento Therapeutics Inc Recent Developments
Table 201. Takara Bio Inc Company Details
Table 202. Takara Bio Inc Business Overview
Table 203. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product
Table 204. Takara Bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022) & (US$ Million)
Table 205. Takara Bio Inc Recent Developments
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chimeric Antigen Receptor Cell Therapy Market Share by Type: 2021 VS 2028
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global Chimeric Antigen Receptor Cell Therapy Market Share by Application: 2021 VS 2028
Figure 5. Acute Leukemia Case Studies
Figure 6. Non-hodgkin's Lymphoma Case Studies
Figure 7. Multiple Myeloma Case Studies
Figure 8. Transplant Rejection Case Studies
Figure 9. Other Case Studies
Figure 10. Chimeric Antigen Receptor Cell Therapy Report Years Considered
Figure 11. Global Chimeric Antigen Receptor Cell Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Chimeric Antigen Receptor Cell Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Chimeric Antigen Receptor Cell Therapy Market Share by Region: 2021 VS 2028
Figure 14. Global Chimeric Antigen Receptor Cell Therapy Market Share by Players in 2021
Figure 15. Global Top Chimeric Antigen Receptor Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor Cell Therapy as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Chimeric Antigen Receptor Cell Therapy Revenue in 2021
Figure 17. North America Chimeric Antigen Receptor Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 19. North America Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 20. North America Chimeric Antigen Receptor Cell Therapy Market Size Share by Country (2017-2028)
Figure 21. United States Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Chimeric Antigen Receptor Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 25. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 26. Europe Chimeric Antigen Receptor Cell Therapy Market Size Share by Country (2017-2028)
Figure 27. Germany Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size Share by Region (2017-2028)
Figure 37. China Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Chimeric Antigen Receptor Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Chimeric Antigen Receptor Cell Therapy Market Size Share by Country (2017-2028)
Figure 47. Mexico Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size Share by Country (2017-2028)
Figure 53. Turkey Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Chimeric Antigen Receptor Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Amgen Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 57. Autolus Therapeutics Plc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 58. Beijing Immunochina Medical Science & Technology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 59. Bellicum Pharmaceuticals Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 60. Bristol-Myers Squibb Co Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 61. bluebird bio Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 62. CARsgen Therapeutics Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 63. Celgene Corp Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 64. Cell Medica Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 65. Cellular Biomedicine Group Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 66. Celularity Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 67. Celyad SA Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 68. Daiichi Sankyo Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 69. Fosun Pharmaceutical AG Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 70. Gilead Sciences Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 71. Guangzhou Anjie Biomedical Technology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 72. Hangzhou Converd Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 73. Hebei Senlang Biotechnology Inc Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 74. HRAIN Biotechnology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 75. Juno Therapeutics Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 76. Kite Pharma Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 77. Nanjing Legend Biotech Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 78. NantKwest Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 79. Nkarta Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 80. Novartis AG Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 81. Ono Pharmaceutical Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 82. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 83. Sorrento Therapeutics Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 84. Takara Bio Inc Revenue Growth Rate in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
Industry Market Size
